CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 852 of 865
Non-Antibody Products
Page 852 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Xestospongin C | An inositol-1,4,5-trisphosphate receptor antagonist; completely blocks the… | 50 µg | 64950-50 | More Info |
| X-Gal | A chromogenic substrate for β-galactosidase; upon cleavage, a blue pi… | 1 g | 16495-1 | More Info |
| X-Gal | A chromogenic substrate for β-galactosidase; upon cleavage, a blue pi… | 5 g | 16495-5 | More Info |
| X-Gal | A chromogenic substrate for β-galactosidase; upon cleavage, a blue pi… | 500 mg | 16495-500 | More Info |
| XIE62-1004 | An inducer of autophagy; increases the number of p62 aggregates, as well a… | 1 mg | 40446-1 | More Info |
| XIE62-1004 | An inducer of autophagy; increases the number of p62 aggregates, as well a… | 10 mg | 40446-10 | More Info |
| XIE62-1004 | An inducer of autophagy; increases the number of p62 aggregates, as well a… | 25 mg | 40446-25 | More Info |
| XIE62-1004 | An inducer of autophagy; increases the number of p62 aggregates, as well a… | 5 mg | 40446-5 | More Info |
| Ximelagatran | An ester prodrug of melagatran, a potent, direct, and reversible thrombin… | 1 mg | 16862-1 | More Info |
| Ximelagatran | An ester prodrug of melagatran, a potent, direct, and reversible thrombin… | 10 mg | 16862-10 | More Info |
| Ximelagatran | An ester prodrug of melagatran, a potent, direct, and reversible thrombin… | 5 mg | 16862-5 | More Info |
| XL019 | A potent, bioavailable JAK inhibitor with preference for JAK2 (IC50 = 2 nM… | 1 mg | 16298-1 | More Info |
| XL019 | A potent, bioavailable JAK inhibitor with preference for JAK2 (IC50 = 2 nM… | 10 mg | 16298-10 | More Info |
| XL019 | A potent, bioavailable JAK inhibitor with preference for JAK2 (IC50 = 2 nM… | 25 mg | 16298-25 | More Info |
| XL019 | A potent, bioavailable JAK inhibitor with preference for JAK2 (IC50 = 2 nM… | 5 mg | 16298-5 | More Info |
| XL092 | A multi-kinase inhibitor; selectively inhibits MET, VEGFR2, Axl, and Mer (… | 10 mg | 37749-10 | More Info |
| XL092 | A multi-kinase inhibitor; selectively inhibits MET, VEGFR2, Axl, and Mer (… | 25 mg | 37749-25 | More Info |
| XL092 | A multi-kinase inhibitor; selectively inhibits MET, VEGFR2, Axl, and Mer (… | 5 mg | 37749-5 | More Info |
| XL147 | A class I PI3K inhibitor (IC50s = 0.039, 0.036, 0.023, and 0.383 µM… | 10 mg | 18011-10 | More Info |
| XL147 | A class I PI3K inhibitor (IC50s = 0.039, 0.036, 0.023, and 0.383 µM… | 25 mg | 18011-25 | More Info |
| XL147 | A class I PI3K inhibitor (IC50s = 0.039, 0.036, 0.023, and 0.383 µM… | 5 mg | 18011-5 | More Info |
| XL184 | A VEGFR2 inhibitor (IC50 = 0.035 nM); selective for VEGFR2 over Ron, EGFR,… | 1 mg | 18464-1 | More Info |
| XL184 | A VEGFR2 inhibitor (IC50 = 0.035 nM); selective for VEGFR2 over Ron, EGFR,… | 10 mg | 18464-10 | More Info |
| XL184 | A VEGFR2 inhibitor (IC50 = 0.035 nM); selective for VEGFR2 over Ron, EGFR,… | 5 mg | 18464-5 | More Info |
| XL184 | A VEGFR2 inhibitor (IC50 = 0.035 nM); selective for VEGFR2 over Ron, EGFR,… | 50 mg | 18464-50 | More Info |
| XL228 | A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… | 10 mg | 21506-10 | More Info |
| XL228 | A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… | 25 mg | 21506-25 | More Info |
| XL228 | A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… | 5 mg | 21506-5 | More Info |
| XL228 | A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… | 50 mg | 21506-50 | More Info |
| XL335 | A potent and selective FXR agonist (EC50 = 4 nM in CV-1 cells transfected… | 10 mg | 23350-10 | More Info |
| XL335 | A potent and selective FXR agonist (EC50 = 4 nM in CV-1 cells transfected… | 25 mg | 23350-25 | More Info |
| XL335 | A potent and selective FXR agonist (EC50 = 4 nM in CV-1 cells transfected… | 5 mg | 23350-5 | More Info |
| XL388 | An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… | 10 mg | 20237-10 | More Info |
| XL388 | An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… | 25 mg | 20237-25 | More Info |
| XL388 | An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… | 5 mg | 20237-5 | More Info |
| XL388 | An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… | 50 mg | 20237-50 | More Info |
| XL647 | A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR,… | 1 mg | 27049-1 | More Info |
| XL647 | A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR,… | 10 mg | 27049-10 | More Info |
| XL647 | A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR,… | 5 mg | 27049-5 | More Info |
| XL888 | An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… | 1 mg | 16309-1 | More Info |
| XL888 | An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… | 10 mg | 16309-10 | More Info |
| XL888 | An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… | 25 mg | 16309-25 | More Info |
| XL888 | An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… | 5 mg | 16309-5 | More Info |
| XL147 analog | An analog of XL147 | 1 mg | 20245-1 | More Info |
| XL147 analog | An analog of XL147 | 10 mg | 20245-10 | More Info |
| XL147 analog | An analog of XL147 | 25 mg | 20245-25 | More Info |
| XL147 analog | An analog of XL147 | 5 mg | 20245-5 | More Info |
| XL147 analog 2 | An analog of XL147 | 1 mg | 16299-1 | More Info |
| XL147 analog 2 | An analog of XL147 | 10 mg | 16299-10 | More Info |
| XL147 analog 2 | An analog of XL147 | 5 mg | 16299-5 | More Info |
| XL147 analog 2 | An analog of XL147 | 50 mg | 16299-50 | More Info |
| XL413 (hydrochloride) | A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… | 1 mg | 24906-1 | More Info |
| XL413 (hydrochloride) | A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… | 10 mg | 24906-10 | More Info |
| XL413 (hydrochloride) | A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… | 25 mg | 24906-25 | More Info |
| XL413 (hydrochloride) | A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… | 5 mg | 24906-5 | More Info |
| XLR12 | A trifluorobutyl analog of XLR11; intended for forensic and research appli… | 1 mg | 14935-1 | More Info |
| XLR12 | A trifluorobutyl analog of XLR11; intended for forensic and research appli… | 10 mg | 14935-10 | More Info |
| XLR12 | A trifluorobutyl analog of XLR11; intended for forensic and research appli… | 5 mg | 14935-5 | More Info |
| XLR11-d5 | An internal standard for the quantification of XLR11 by GC- or LC-MS; regu… | 1 mg | 11771-1 | More Info |
| XLR11-d5 | An internal standard for the quantification of XLR11 by GC- or LC-MS; regu… | 5 mg | 11771-5 | More Info |
| XLR11-d5 | An internal standard for the quantification of XLR11 by GC- or LC-MS; regu… | 500 µg | 11771-500 | More Info |
| XLR11 Degradant | A common impurity observed during GC-MS analysis of samples containing XLR… | 1 mg | 14055-1 | More Info |
| XLR11 Degradant | A common impurity observed during GC-MS analysis of samples containing XLR… | 10 mg | 14055-10 | More Info |
| XLR11 Degradant | A common impurity observed during GC-MS analysis of samples containing XLR… | 5 mg | 14055-5 | More Info |
| XLR11-d5 (exempt preparation) | An internal standard for the quantification of XLR11 by GC- or LC-MS; prov… | 1 mg | 22857-1 | More Info |
| XLR11 6-hydroxyindole metabolite | An expected minor monohydroxylated urinary metabolite of XLR11; intended f… | 1 mg | 14354-1 | More Info |
| XLR11 6-hydroxyindole metabolite | An expected minor monohydroxylated urinary metabolite of XLR11; intended f… | 10 mg | 14354-10 | More Info |
| XLR11 6-hydroxyindole metabolite | An expected minor monohydroxylated urinary metabolite of XLR11; intended f… | 5 mg | 14354-5 | More Info |
| XLR11 N-(2-fluoropentyl) isomer | A variant of XLR11 with the fluorine at the 2 position rather than the 5 p… | 1 mg | 11767-1 | More Info |
| XLR11 N-(2-fluoropentyl) isomer | A variant of XLR11 with the fluorine at the 2 position rather than the 5 p… | 100 µg | 11767-100 | More Info |
| XLR11 N-(2-fluoropentyl) isomer | A variant of XLR11 with the fluorine at the 2 position rather than the 5 p… | 500 µg | 11767-500 | More Info |
| XLR11 N-(3-fluoropentyl) isomer | An analytical reference standard that is structurally categorized as a syn… | 1 mg | 11768-1 | More Info |
| XLR11 N-(3-fluoropentyl) isomer | An analytical reference standard that is structurally categorized as a syn… | 100 µg | 11768-100 | More Info |
| XLR11 N-(3-fluoropentyl) isomer | An analytical reference standard that is structurally categorized as a syn… | 500 µg | 11768-500 | More Info |
| XLR11 N-(4-fluoropentyl) isomer | An isomer of XLR11 which has the fluorine atom placed on the 4 position, r… | 1 mg | 11769-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile